SAMANTHA ALTERGOTT STERNS: Open Payments
NPI 1942911094 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 29 payments from 10 companies in 2025. Trend: 2023 $237 · 2024 $1,243 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $161 |
| ABBVIE INC. | 5 | $100 |
| Lilly USA, LLC | 6 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| SANOFI-AVENTIS U.S. LLC | 2 | $68 |
| Amgen Inc. | 1 | $30 |
| PFIZER INC. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Intra-Sana Laboratories | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
Products named: MOUNJARO, QULIPTA, TZIELD, Rybelsus, FARXIGA, Ozempic, OTEZLA, NURTEC ODT.
Industry payments across NV — which companies pay providers there.
